Clinical Trials Logo

Weight Loss clinical trials

View clinical trials related to Weight Loss.

Filter by:

NCT ID: NCT03610958 Completed - Obesity Clinical Trials

Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.

Start date: September 4, 2014
Phase: N/A
Study type: Interventional

Study design to demonstrate the safety and performance of the Epitomee Device

NCT ID: NCT03609463 Completed - Clinical trials for Diabetes Mellitus, Type 2

Promoting Weight Loss and Stress Reduction in Overweight and Obese Patients With Type 2 Diabetes

Start date: March 27, 2018
Phase: N/A
Study type: Interventional

This is a feasibility and acceptability study of a 16-month single-blind randomized controlled trial (RCT) designed to test the initial effectiveness of a well-being and small lifestyle changes intervention aimed at promoting weight loss and stress reduction in overweight and obese patients with type 2 diabetes. Primary goals of this study are to 1) evaluate study feasibility and patient acceptability, 2) develop a tailored protocol of a behavioral intervention for overweight or obese patients with type 2 diabetes that takes stress and well-being into consideration, 3) evaluate appropriateness of research procedures and measures, 4) examine effect size estimates of key outcomes to provide essential data to inform a larger efficacy trial, 5) determine whether clinically significant improvements occurred in any key outcomes.

NCT ID: NCT03607305 Completed - Weight Loss Clinical Trials

Impact of Biliopancreatic Limb Lenght on Long-term Weight Loss After Roux-en-Y Gastric Bypass

Start date: January 2011
Phase: Phase 3
Study type: Interventional

Patients were randomly assigned into 2 groups: those patients undergoing RYGB with a BPL of 70cm and those ones undergoing RYGB with a BPL of 120 cm. Excess BMI loss 5 years after surgery was investigated

NCT ID: NCT03605888 Completed - Physical Activity Clinical Trials

Koa Family: California's Obesity Prevention Project

Start date: August 16, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to learn if a new whole-person lifestyle program improves the health of low-income mothers.

NCT ID: NCT03602001 Completed - Clinical trials for Overweight and Obesity

Attentive Eating for Weight Loss

Start date: September 7, 2017
Phase: N/A
Study type: Interventional

This trial examined whether a smartphone application designed to encourage a more attentive eating style could help people to lose weight, compared to a control group.

NCT ID: NCT03600311 Completed - Weight Loss Clinical Trials

Resistance Exercise and Protein During Weight Loss

RIDE
Start date: August 31, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if post-exercise protein supplementation can rescue the anabolic response of muscle and bone to resistance exercise during caloric restriction.

NCT ID: NCT03582722 Completed - Clinical trials for Polybrominated Biphenyl Poisoning

Weight Loss Aid in an Exposed Population

Start date: September 14, 2018
Phase: Phase 4
Study type: Interventional

This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).

NCT ID: NCT03580057 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Weight Loss and Lactation (the EVA-trial)

EVA
Start date: January 30, 2018
Phase: N/A
Study type: Interventional

A randomized controlled trial aiming to investigate the effects and possible interactions of diet induced weight loss and lactation on cardiometabolic profile

NCT ID: NCT03572218 Completed - Obesity Clinical Trials

Psychological Intervention to Reduce Weight Bias Internalization

Start date: April 10, 2018
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to test the effects on WBI of a novel psychological intervention combined with standard behavioral weight loss (BWL) treatment, as compared to BWL alone. Participants will be a total of 72 men and women seeking weight loss, ages 18-65 years, with a body mass index (BMI) of 30 kg/m2 or above, a history of experiencing weight bias, and elevated levels of WBI. Participants will attend a screening visit in which they will complete a behavioral evaluation with a psychologist and a medical history that will be reviewed by a nurse practitioner or physician. Questionnaires assessing experiences and internalization of weight bias, with confirmation by interviewer assessment during the behavioral evaluation, will be used to determine whether participants meet criteria for having high levels of WBI. Eligible consenting participants will be randomly assigned to the standard BWL intervention (n = 36) or the BWL + BIAS program (n = 36). All participants will attend weekly, 90-minute group meetings for 12 weeks (12 visits). In the BWL + stigma intervention, 60 minutes will be devoted to BWL and 30 minutes to weight stigma. In the standard BWL treatment group, the additional 30 minutes will be devoted to sharing recipes and food preparation tips. Following 12 weeks of weight loss treatment, participants will attend group meetings focused on weight loss maintenance, every-other-week from weeks 13-16 (2 visits), and monthly from weeks 17-26 (2 visits). Maintenance sessions in the BWL + stigma group will continue to incorporate discussion of WBI. Assessments - which include questionnaires and measurements of body weight - will occur at baseline and weeks 12 and 26. Weight will be measured at every group meeting for clinical purposes.

NCT ID: NCT03571893 Completed - Obesity Clinical Trials

Study of an International Commercial Program on Weight Loss and Health Outcomes

Start date: June 19, 2018
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial (RCT) of the Weight Watchers (WW) Freestyle ® (Flex® in UK) weight loss program compared to a control group following a do-it-yourself (DIY) approach for 12 months. Participants in the United States, Canada and the UK (n=360 total) will be randomly assigned to either participate in the commercially available WW program in their local community or to follow their own approach for weight loss. This study will examine the impact of the WW program on weight, fitness levels, quality of life, health behaviors and other health outcomes in overweight and obese adults after 3 and 12 months.